Ticker research · released through 2026-09-20
Which members of Congress bought CRISPR Therapeutics AG ($CRSP)?
As of 2026-09-27, 3 members of Congress disclosed buying CRISPR Therapeutics AG (CRSP) in CopyGov's publicly released record. The most recent published buy was attributed to Thomas Suozzi on 2021-09-23; its modeled entry was 2021-09-24. Copying at the first close after publication returned -53.5% to 2026-09-25, or -138.9 points versus SPY.
Members with disclosed buys
Thomas Suozzi
1 released CRSP buys ↗Marjorie Taylor Greene
1 released CRSP buys ↗Rohit Khanna
1 released CRSP buys ↗Disclosure-by-disclosure copy returns
| Member | Published | Modeled entry | Copy return to 2026-09-25 | SPY same dates | Original PTR |
|---|---|---|---|---|---|
| Thomas Suozzi | 2021-09-23 | 2021-09-24 | -53.5% · $-535 per $1,000 | +85.4% · -138.9 pts excess | Official source ↗ |
| Marjorie Taylor Greene | 2021-02-19 | 2021-02-22 | -60.9% · $-609 per $1,000 | +114.7% · -175.7 pts excess | Official source ↗ |
| Rohit Khanna | 2020-12-16 | 2020-12-17 | -63.7% · $-637 per $1,000 | +124.2% · -187.9 pts excess | Official source ↗ |
Common questions
Who in Congress bought CRSP?
Thomas Suozzi, Marjorie Taylor Greene, Rohit Khanna have publicly released CRSP purchase signals in CopyGov through 2026-09-20. Each row below links to its original filing.
When did Pelosi buy CRSP?
No Pelosi-household CRSP purchase is currently in CopyGov's released record through 2026-09-20.
What would copying have returned?
For the latest released CRSP buy, copying at the first close after publication returned -53.5% to 2026-09-25, compared with +85.4% for SPY over the same dates. The excess was -138.9 percentage points after 10 basis points per side.
The model enters at the first completed close after publication, not the original trade price, assumes 10 basis points per side, and ignores later sales. Verify ownership and amounts in the original PTR. Past outcomes are not forecasts.
Get Congress trade alerts →